Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Neointima

ng-nitroarginine methyl ester has been researched along with Neointima in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bendeck, MP; Breen, DM; Dandona, P; Dolinsky, VW; Dyck, JR; Ghanim, H; Giacca, A; Guo, J; Heximer, SP; Mroziewicz, M; Tsiani, EL; Zhang, H1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Neointima

ArticleYear
Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
    Atherosclerosis, 2012, Volume: 222, Issue:2

    Topics: Administration, Oral; Animals; Aorta; Cardiovascular Agents; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Femoral Artery; Gene Expression Regulation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Neointima; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Vascular System Injuries

2012